Faye Vazvaei-Smith, Enaksha Wickremsinhe, Eric Woolf, Chongwoo Yu
{"title":"ICH M10 Bioanalytical Method Validation Guideline-1 year Later","authors":"Faye Vazvaei-Smith, Enaksha Wickremsinhe, Eric Woolf, Chongwoo Yu","doi":"10.1208/s12248-024-00974-y","DOIUrl":null,"url":null,"abstract":"<p>The International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) adopted Guideline M10 entitled \"Bioanalytical Method Validation and Study Sample Analysis\" in May 2022. In October 2023, approximately one year after the adoption of the ICH M10 guideline, a \"Hot Topic\" session was held during the AAPS PharmSci 360 meeting to discuss the implementation of the guideline. The session focused on items the bioanalytical community felt were challenging to implement or ambiguous within the guideline. These topics included cross-validation, parallelism, comparative bioavailability studies, combination drug stability, endogenous analyte bioanalysis, and dilution QCs. In addition, the regulatory perspective on the guideline was presented. This report provides a summary of the Hot Topic session.</p><h3 data-test=\"abstract-sub-heading\">Graphical Abstract</h3>\n","PeriodicalId":501692,"journal":{"name":"The AAPS Journal","volume":"14 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The AAPS Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1208/s12248-024-00974-y","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) adopted Guideline M10 entitled "Bioanalytical Method Validation and Study Sample Analysis" in May 2022. In October 2023, approximately one year after the adoption of the ICH M10 guideline, a "Hot Topic" session was held during the AAPS PharmSci 360 meeting to discuss the implementation of the guideline. The session focused on items the bioanalytical community felt were challenging to implement or ambiguous within the guideline. These topics included cross-validation, parallelism, comparative bioavailability studies, combination drug stability, endogenous analyte bioanalysis, and dilution QCs. In addition, the regulatory perspective on the guideline was presented. This report provides a summary of the Hot Topic session.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
